Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension
Status:
Withdrawn
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of Remodulin in the treatment of adult
patients with congenital heart disease and pulmonary hypertension. Baseline and
post-treatment cardiopulmonary exercise tests will be performed.